Basu S - Search Results

1

The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression.

Fisher MJ, Basu S, Dombi E, Yu JQ, Widemann BC, Pollock AN, Cnaan A, Zhuang H, Phillips PC, Alavi A. Fisher MJ, et al. Among authors: basu s. J Neurooncol. 2008 Apr;87(2):165-71. doi: 10.1007/s11060-007-9501-5. Epub 2007 Dec 11. J Neurooncol. 2008. PMID: 18071635

2

Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease: a case study and review of the literature.

Basu S, Nair N. Basu S, et al. J Neurooncol. 2006 Oct;80(1):91-5. doi: 10.1007/s11060-006-9161-x. Epub 2006 Jul 19. J Neurooncol. 2006. PMID: 16850110

3

Basu S, Alavi A. Basu S, et al. Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):441-3. doi: 10.1007/s00259-006-0264-6. Eur J Nucl Med Mol Imaging. 2007. PMID: 17072613 No abstract available.

4

FDG-PET in the clinical management of carcinoma of unknown primary with metastatic cervical lymphadenopathy: shifting gears from detecting the primary to planning therapeutic strategies.

Basu S, Alavi A. Basu S, et al. Eur J Nucl Med Mol Imaging. 2007 Mar;34(3):427-8. doi: 10.1007/s00259-006-0313-1. Epub 2006 Dec 29. Eur J Nucl Med Mol Imaging. 2007. PMID: 17195072 No abstract available.

5

Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites?

Basu S, Alavi A. Basu S, et al. Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):604-5. doi: 10.1007/s00259-006-0315-z. Eur J Nucl Med Mol Imaging. 2007. PMID: 17206414 No abstract available.

6

Is PET-CT the only option?

Alavi A, Mavi A, Basu S, Fischman A. Alavi A, et al. Among authors: basu s. Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):819-21. doi: 10.1007/s00259-006-0340-y. Eur J Nucl Med Mol Imaging. 2007. PMID: 17216469 No abstract available.

7

Potential clinical role of fluorodeoxyglucose-positron emission tomography in assessing primary or secondary lymphomas of the parotid gland.

Basu S, Mahne A, Iruvuri S, Alavi A. Basu S, et al. Clin Lymphoma Myeloma. 2007 Jan;7(4):309-14. doi: 10.3816/CLM.2007.n.008. Clin Lymphoma Myeloma. 2007. PMID: 17324340

8

Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.

Basu S, Alavi A. Basu S, et al. J Clin Oncol. 2007 Apr 1;25(10):1297; author reply 1297-9. doi: 10.1200/JCO.2006.10.0123. J Clin Oncol. 2007. PMID: 17401027 No abstract available.

9

Abramson RG, Mavi A, Cermik T, Basu S, Wehrli NE, Houseni M, Mishra S, Udupa J, Lakhani P, Maidment AD, Torigian DA, Alavi A. Abramson RG, et al. Among authors: basu s. Semin Nucl Med. 2007 May;37(3):146-53. doi: 10.1053/j.semnuclmed.2007.01.003. Semin Nucl Med. 2007. PMID: 17418148 Review.

10

Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: implications for normal variation, aging and diseased states.

Basu S, Zaidi H, Houseni M, Bural G, Udupa J, Acton P, Torigian DA, Alavi A. Basu S, et al. Semin Nucl Med. 2007 May;37(3):223-39. doi: 10.1053/j.semnuclmed.2007.01.005. Semin Nucl Med. 2007. PMID: 17418154 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,757 results

Search Page

Filters